International Clinical Trial: Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07469072) titled 'Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Zhujiang Hospital

Condition: Continuous Renal Replacement Therapy (CRRT)

Intervention: Drug: Nafamostat Low-Dose Group

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: February 25, 2026

Target Sample Size: 92

Countries of Recruitment: China...